AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Jun 13, 2022
50715_rns_2022-06-13_21a7bbdc-d253-427f-a7ff-320dcb7720ae.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
13 June 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Descriptionof relevantsecurities | Descriptionof products | Nature ofdealings | Number ofreferencesecurities towhich thederivativesrelate | Maturitydate /closing outdate | Referenceprice | Total amountpaid / received | Resultantbalance(includingthose of anyperson withwhom there isan agreementorunderstanding) |
|---|---|---|---|---|---|---|---|---|---|
| CICC PuchengInvestment Co.,Ltd. | 10 June2022 | Derivatives | Other types ofproducts | Closing out of aderivative contract | 4,000 | 19 February2025 | $28.2000 | $112,800.0000 | 74,000 |
| Derivatives | Other types ofproducts | Closing out of aderivative contract | 6,000 | 22 May 2024 | $28.2000 | $169,200.0000 | 58,000 | ||
| Derivatives | Other types ofproducts | Closing out of aderivative contract | 4,000 | 14 June 2023 | $28.2530 | $113,011.8900 | 74,000 |
==> picture [71 x 43] intentionally omitted <==
Public Disclosure Form
| Derivatives | Other types ofproducts | Closing out of aderivative contract | 6,000 | 14 June 2023 | $28.2530 | $169,517.8400 | 58,000 |
|---|
End
Note:
CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20